Skip to content

Axial Spondyloarthritis in Primary care patients with chronic low back pain; a cross-sectional stratified validation study

Axial Spondyloarthritis in Primary care patients with chronic low back pain; a cross-sectional stratified validation study - CAFASPA-II

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35785
Enrollment
800
Registered
2011-05-19
Start date
2011-06-08
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation of the axial joints Spondylarthropathy

Interventions

None listed

Sponsors

The Rotterdam Institute of Rheumatology
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: A-Specific low back pain Symptom duration more than 12 weeks Age between 20-45

Exclusion criteria

Exclusion criteria: Impossible to communicate Low back pain due to trauma Pregnancy Metal protheses Claustrofobia Unwilling to participate in MRI

Design outcomes

Primary

MeasureTime frame
The primary objective of the CAFASPA-II study is three-fold 1.Validate the prevalence of aSpA in young patients with Chronic Low Back Pain (CLBP) 2. To estimate the prevalence's of axial SpA in patients with chronic low back pain in three strata of symptom duration (3 months - 1 year, 1-5 years, > 5 years of having CLBP) 3. To perform external validation on the recently developed referral tool for GP's to identify patients at risk for aSpA.

Secondary

MeasureTime frame
The secondary objectives are : 1. to estimate the additive value of the presence of "Red Flags" in patients with aSpA. 2. to get insight on the specificity (false positive findings) OF MRI OF THE SACROILIAC JOINTS IN PRIMARY CARE. 3. development of questionnaires that differentiate between inflammatory and non-inflammatory back pain in relation to the diagnosis of SpA will be compared with a view to creating a simple referral model for SpA that can be applied in the primary-care sector.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)